| 3013- | RosA, | Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro |
| - | in-vitro, | NA, | NA |
| 3012- | RosA, | Rad, | Rosmarinic Acid Prevents Radiation-Induced Pulmonary Fibrosis Through Attenuation of ROSMYPT1TGFβ1 Signaling Via miR-19b-3p |
| - | in-vitro, | Nor, | IMR90 |
| 3011- | RosA, | Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition |
| - | in-vitro, | GBM, | SH-SY5Y | - | in-vitro, | Lung, | A549 | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | Nor, | MCF10 |
| 3010- | RosA, | Exploring the mechanism of rosmarinic acid in the treatment of lung adenocarcinoma based on bioinformatics methods and experimental validation |
| - | in-vitro, | Lung, | A549 | - | in-vivo, | NA, | NA |
| 3009- | RosA, | Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells |
| - | in-vitro, | AML, | U937 |
| 3008- | RosA, | Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related CASP8/CASP3/NLRP3 genes in human metastatic melanoma cells |
| - | in-vitro, | Melanoma, | SK-MEL-28 |
| 3007- | RosA, | Hepatoprotective effects of rosmarinic acid: Insight into its mechanisms of action |
| - | Review, | NA, | NA |
| 3006- | RosA, | Rosmarinic acid attenuates glioblastoma cells and spheroids’ growth and EMT/stem-like state by PTEN/PI3K/AKT downregulation and ERK-induced apoptosis |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | GBM, | LN229 |
| 3005- | RosA, | Nanoformulated rosemary extract impact on oral cancer: in vitro study |
| - | in-vitro, | Laryn, | HEp2 |
| 3004- | RosA, | Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system |
| - | in-vitro, | Nor, | HSC-T6 |
| 3003- | RosA, | Comprehensive Insights into Biological Roles of Rosmarinic Acid: Implications in Diabetes, Cancer and Neurodegenerative Diseases |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3002- | RosA, | Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols |
| - | Review, | Var, | NA |
| 3001- | RosA, | Therapeutic Potential of Rosmarinic Acid: A Comprehensive Review |
| - | Review, | Var, | NA |
| 3039- | RosA, | Rosmarinic acid liposomes suppress ferroptosis in ischemic brain via inhibition of TfR1 in BMECs |
| - | in-vivo, | Nor, | NA | - | in-vivo, | Stroke, | NA |
| 3038- | RosA, | Prooxidant action of rosmarinic acid: transition metal-dependent generation of reactive oxygen species |
| - | in-vitro, | Nor, | NA |
| 3037- | RosA, | Unraveling rosmarinic acid anticancer mechanisms in oral cancer malignant transformation |
| - | in-vitro, | Oral, | SCC9 | - | in-vitro, | Oral, | HSC3 |
| 3036- | RosA, | Anti-Warburg effect of rosmarinic acid via miR-155 in colorectal carcinoma cells |
| - | in-vitro, | CRC, | HCT8 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | LS174T |
| 3035- | RosA, | Rosmarinic Acid Decreases the Malignancy of Pancreatic Cancer Through Inhibiting Gli1 Signaling |
| - | in-vitro, | PC, | NA | - | in-vivo, | NA, | NA |
| 3034- | RosA, | RES, | Ba, | The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells |
| - | in-vitro, | BC, | MCF7 |
| 3033- | RosA, | Rosemary (Rosmarinus officinalis) Extract Modulates CHOP/GADD153 to Promote Androgen Receptor Degradation and Decreases Xenograft Tumor Growth |
| - | in-vitro, | Pca, | 22Rv1 | - | in-vitro, | Pca, | LNCaP | - | vitro+vivo, | NA, | NA |
| 3031- | RosA, | Effects of rosmarinic acid against aflatoxin B1 and ochratoxin-A-induced cell damage in a human hepatoma cell line (Hep G2) |
| - | in-vitro, | Liver, | HepG2 |
| 3030- | RosA, | Anticancer Activity of Rosmarinus officinalis L.: Mechanisms of Action and Therapeutic Potentials |
| - | Review, | Var, | NA |
| 3029- | RosA, | Rosmarinic Acid, a Component of Rosemary Tea, Induced the Cell Cycle Arrest and Apoptosis through Modulation of HDAC2 Expression in Prostate Cancer Cell Lines |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | DU145 |
| 3028- | RosA, | Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer’s disease |
| - | in-vitro, | AD, | HT22 | - | in-vivo, | NA, | NA |
| 1748- | RosA, | The Role of Rosmarinic Acid in Cancer Prevention and Therapy: Mechanisms of Antioxidant and Anticancer Activity |
| - | Review, | Var, | NA |
| 1749- | RosA, | Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer |
| - | Review, | Var, | NA |
| 1747- | RosA, | Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review |
| - | Review, | BC, | MDA-MB-231 | - | Review, | BC, | MDA-MB-468 |
| 1746- | RosA, | Rosmarinic acid sensitizes cell death through suppression of TNF-α-induced NF-κB activation and ROS generation in human leukemia U937 cells |
| - | in-vitro, | AML, | U937 |
| 1745- | RosA, | Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 1744- | RosA, | Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity |
| - | Review, | Var, | NA |
| 1743- | RosA, | New insights into the competition between antioxidant activities and pro-oxidant risks of rosmarinic acid |
| - | Analysis, | Var, | NA |
| 1742- | RosA, | Rosmarinic acid, a natural polyphenol, has a potential pro-oxidant risk via NADH-mediated oxidative DNA damage |
| - | Analysis, | Var, | NA |
| 3616- | RosA, | Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders |
| - | Review, | AD, | NA |
| 3615- | RosA, | Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer's Disease, Parkinson's Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 3617- | RosA, | Aroma, | Effect of aromatherapy on patients with Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 3618- | RosA, | Antioxidant and Antimicrobial Properties of Rosemary (Rosmarinus officinalis, L.): A Review |
| - | Review, | AD, | NA |
| 3619- | RosA, | Rosmarinic acid suppresses Alzheimer’s disease development by reducing amyloid β aggregation by increasing monoamine secretion |
| - | Review, | AD, | NA |
| 3620- | RosA, | Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer's Disease |
| - | in-vivo, | AD, | NA |
| 3621- | RosA, | Short-Term Study on the Effects of Rosemary on Cognitive Function in an Elderly Population |
| - | Trial, | AD, | NA |
| 3622- | RosA, | Rosmarinic acid prevents lipid peroxidation and increase in acetylcholinesterase activity in brain of streptozotocin-induced diabetic rats |
| - | in-vivo, | Diabetic, | NA |
| 3623- | RosA, | Rosmarinic acid inhibits some metabolic enzymes including glutathione S-transferase, lactoperoxidase, acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase isoenzymes |
| - | in-vitro, | AD, | NA |
| 3632- | RosA, | CA, | QC, | Evolving Role of Natural Products from Traditional Medicinal Herbs in the Treatment of Alzheimer's Disease |
| - | Review, | AD, | NA |
| 3757- | RosA, | Sage, | Cro, | NarG, | Caff | Food-derived Acetylcholinesterase Inhibitors as Potential Agents against Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 3792- | RosA, | Molecular docking and dynamics simulations revealed the potential inhibitory activity of honey-iQfood ingredients against GSK-3β and CDK5 protein targets for brain health |
| - | Analysis, | AD, | NA |
| 3755- | RosA, | CUR, | Development of Acetylcholinesterase (AChE) Inhibitor |
| - | Study, | AD, | NA |
| 1048- | RosA, | GSL, | Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis |
| - | in-vivo, | Colon, | MC38 |
| 7375- | RS, | Regulation of hippo signaling mediated apoptosis by Rauvolfia tetraphylla in triple-negative breast cancer |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7392- | RS, | Blood pressure lowering efficacy of reserpine for primary hypertension |
| - | Review, | Nor, | NA |
| 7381- | RS, | In-vitro anticancer activity of Rauvolfia tetraphylla extract on mcf-7 breast cancer cell lines |
| - | in-vitro, | BC, | MCF7 |
| 7380- | RS, | GoldNP, | A Comparative Antibacterial, Antioxidant, and Antineoplastic Potential of Rauwolfia serpentina (L.) Leaf Extract with Its Biologically Synthesized Gold Nanoparticles (R-AuNPs) |
| - | in-vitro, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid